Concrete information on continued Pergolide availability is difficult to come by. I did receive this update from an AAEP email announcement on 5/11/07:

“The AAEP has, for the past several years, been working closely with the Center for Veterinary Medicine at the Food and Drug Administration to understand the policies governing compounding as it relates to equine practice. As a result of the recent withdrawal of pergolide from the market due to human health concerns, the AAEP contacted the FDA in an effort to educate and emphasize the importance of this drug to equine practitioners and their clientele. The AAEP received the communication below from the FDA and with it we feel that there will not be a crisis due to a pergolide shortage. The FDA recognizes the importance of these drugs and because of a healthy alliance with the AAEP, the Agency learned of the situation quickly and made its decision to apply regulatory discretion to the compounding of pergolide from bulk sources. Compounding pharmacies should not experience any shortage of the bulk product.”

Recent article from thehorse.com about the situation surrounding pergolide:

http://www.thehorse.com/viewarticle.aspx?ID=9526